News

Healio2d
Tirzepatide bests semaglutide for weight loss in adults with obesity
Tirzepatide conferred significantly greater weight loss than semaglutide at 72 weeks for adults with overweight or obesity, ...
News-Medical.Net on MSN1d
Animal research reveals metabolic differences between tirzepatide and semaglutide
New animal research being presented at this year's European Congress on Obesity (ECO) in Malaga, Spain (11-14 May), reveals ...
Fierce Biotech1d
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Novo Nordisk is making yet another bet on obesity, offering Septerna more than $200 million in upfront and near-term payments ...
Research Uncovers Tirzepatide, Semaglutide Mechanisms
New animal research being presented at this year's European Congress on Obesity (ECO) in Malaga, Spain (11-14 May), reveals distinct metabolic ...
The New York Sun4d
Big Pharma Is Winning the Price War Over Weight Loss Drugs Like Ozempic: Will RFK Jr. and His MAHA Allies Push Back?
Brigham Buhler, a MAHA influencer and biotech entrepreneur, has Robert F. Kennedy’s ear. But will RFK listen to his call to ...
Pharmabiz3d
Mounjaro showed superior weight loss over Wegovy in complete SURMOUNT-5 trial results in The New England Journal of Medicine
Our Bureau, Mumbai Monday, May 12, 2025, 14:45 Hrs [IST] ...
The Pharma Letter2d
Zepbound wins in weight loss duel
They are the two drugs of the moment, the weight loss products promising a miraculous solution to obesity and—in data ...